These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30953486)

  • 1. Network-based characterization of drug-protein interaction signatures with a space-efficient approach.
    Tabei Y; Kotera M; Sawada R; Yamanishi Y
    BMC Syst Biol; 2019 Apr; 13(Suppl 2):39. PubMed ID: 30953486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferring protein domains associated with drug side effects based on drug-target interaction network.
    Iwata H; Mizutani S; Tabei Y; Kotera M; Goto S; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S18. PubMed ID: 24565527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.
    Luo Y; Zhao X; Zhou J; Yang J; Zhang Y; Kuang W; Peng J; Chen L; Zeng J
    Nat Commun; 2017 Sep; 8(1):573. PubMed ID: 28924171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.
    Tabei Y; Pauwels E; Stoven V; Takemoto K; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i487-i494. PubMed ID: 22962471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples.
    Cheng Z; Zhou S; Wang Y; Liu H; Guan J; Chen YP
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1832-1843. PubMed ID: 28113437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating multi-scale neighbouring topologies and cross-modal similarities for drug-protein interaction prediction.
    Xuan P; Zhang Y; Cui H; Zhang T; Guo M; Nakaguchi T
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-target interaction prediction via class imbalance-aware ensemble learning.
    Ezzat A; Wu M; Li XL; Kwoh CK
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):509. PubMed ID: 28155697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalable prediction of compound-protein interactions using minwise hashing.
    Tabei Y; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S3. PubMed ID: 24564870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical Property Labels as Molecular Descriptors for Improved Analysis of Compound-Protein and Compound-Compound Networks.
    Kotera M
    Methods Mol Biol; 2018; 1825():211-225. PubMed ID: 30334207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semi-supervised method for drug-target interaction prediction with consistency in networks.
    Chen H; Zhang Z
    PLoS One; 2013; 8(5):e62975. PubMed ID: 23667553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prediction of network drug target based on improved model of bipartite graph valuation].
    Liu X; Lu P; Zuo X; Chen J; Yang H; Yang Y; Gao Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):125-9. PubMed ID: 22737836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures.
    Huang LC; Wu X; Chen JY
    Proteomics; 2013 Jan; 13(2):313-24. PubMed ID: 23184540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of protein-chemical complex structures reveal new targets for established drugs.
    Kalinina OV; Wichmann O; Apic G; Russell RB
    PLoS Comput Biol; 2011 May; 7(5):e1002043. PubMed ID: 21573205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Biological Networks for Drug Target Prediction and Prioritization.
    Ji X; Freudenberg JM; Agarwal P
    Methods Mol Biol; 2019; 1903():203-218. PubMed ID: 30547444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-domain interaction networks in myocardial infarction.
    Wang H; Zheng H; Azuaje F; Zhao XM
    IEEE Trans Nanobioscience; 2013 Sep; 12(3):182-8. PubMed ID: 23974657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KenDTI: An Ensemble Model for Predicting Drug-Target Interaction by Integrating Multi-Source Information.
    Yu Z; Lu J; Jin Y; Yang Y
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1305-1314. PubMed ID: 33877984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering patterns in drug-protein interactions based on their fingerprints.
    Luo W; Chan KC
    BMC Bioinformatics; 2012 Jun; 13 Suppl 9(Suppl 9):S4. PubMed ID: 22901089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlated sequence-signatures as markers of protein-protein interaction.
    Sprinzak E; Margalit H
    J Mol Biol; 2001 Aug; 311(4):681-92. PubMed ID: 11518523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.